Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Withdrawn × Other neoplasm × Clear all

Phase

Phase 1 4 Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Unknown 3 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Head & Neck 5 Breast 4 Other hematologic neoplasm 3 Lymphoid 3 Dermatologic 3 Sarcoma 2 Genitourinary 2 CNS 2 Thoracic 1 Other neoplasm 1 Myeloid 1 Gynecologic 1

Conditions

Precancerous Conditions 1 Keratosis, Actinic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡